Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF784
|
ENSG00000179922.5 | zinc finger protein 784 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF784 | hg19_v2_chr19_-_56135928_56135967 | -0.59 | 6.0e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_+_41029235 | 4.74 |
ENST00000380618.1
|
B3GALT5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
chr1_-_153029980 | 4.19 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chr22_-_37640456 | 3.89 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr22_-_37640277 | 3.76 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr15_+_40453204 | 3.75 |
ENST00000287598.6
ENST00000412359.3 |
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B |
chr1_+_32042131 | 3.62 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr1_+_32042105 | 3.61 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr15_-_74501360 | 3.05 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr18_+_21529811 | 2.76 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
chr2_-_72375167 | 2.50 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr1_-_186649543 | 2.43 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
chr1_+_203651937 | 2.19 |
ENST00000341360.2
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr14_-_55658252 | 2.16 |
ENST00000395425.2
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr14_-_55658323 | 2.15 |
ENST00000554067.1
ENST00000247191.2 |
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr11_+_33061543 | 2.14 |
ENST00000432887.1
ENST00000528898.1 ENST00000531632.2 |
TCP11L1
|
t-complex 11, testis-specific-like 1 |
chr15_-_70387120 | 1.90 |
ENST00000539550.1
|
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
chr9_+_116037922 | 1.89 |
ENST00000374198.4
|
PRPF4
|
pre-mRNA processing factor 4 |
chr18_-_31802056 | 1.85 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chr10_+_28966271 | 1.82 |
ENST00000375533.3
|
BAMBI
|
BMP and activin membrane-bound inhibitor |
chr16_-_57831914 | 1.80 |
ENST00000421376.2
|
KIFC3
|
kinesin family member C3 |
chr17_+_73717407 | 1.77 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
chr18_+_61254570 | 1.77 |
ENST00000344731.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr18_+_61254534 | 1.77 |
ENST00000269489.5
|
SERPINB13
|
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr12_-_91505608 | 1.75 |
ENST00000266718.4
|
LUM
|
lumican |
chr20_-_56285595 | 1.69 |
ENST00000395816.3
ENST00000347215.4 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr20_-_56286479 | 1.67 |
ENST00000265626.4
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr17_+_73717551 | 1.63 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
chr7_+_26332645 | 1.51 |
ENST00000396376.1
|
SNX10
|
sorting nexin 10 |
chr10_-_76859247 | 1.50 |
ENST00000472493.2
ENST00000605915.1 ENST00000478873.2 |
DUSP13
|
dual specificity phosphatase 13 |
chr5_-_137674000 | 1.49 |
ENST00000510119.1
ENST00000513970.1 |
CDC25C
|
cell division cycle 25C |
chr2_+_54683419 | 1.48 |
ENST00000356805.4
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
chr1_-_85155939 | 1.45 |
ENST00000603677.1
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr17_+_4736627 | 1.42 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr7_-_107643674 | 1.40 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr2_-_70780572 | 1.38 |
ENST00000450929.1
|
TGFA
|
transforming growth factor, alpha |
chr9_+_132815985 | 1.33 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
chr17_+_1933404 | 1.33 |
ENST00000263083.6
ENST00000571418.1 |
DPH1
|
diphthamide biosynthesis 1 |
chr12_+_57828521 | 1.33 |
ENST00000309668.2
|
INHBC
|
inhibin, beta C |
chr15_-_59665062 | 1.31 |
ENST00000288235.4
|
MYO1E
|
myosin IE |
chr2_-_70780770 | 1.29 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
chr16_-_57831676 | 1.29 |
ENST00000465878.2
ENST00000539578.1 ENST00000561524.1 |
KIFC3
|
kinesin family member C3 |
chr8_-_145018905 | 1.29 |
ENST00000398774.2
|
PLEC
|
plectin |
chr2_-_85636928 | 1.28 |
ENST00000449030.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr8_-_9008206 | 1.28 |
ENST00000310455.3
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr18_-_31802282 | 1.25 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
chr17_-_1394940 | 1.16 |
ENST00000570984.2
ENST00000361007.2 |
MYO1C
|
myosin IC |
chr15_+_40674963 | 1.15 |
ENST00000448395.2
|
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
chr19_-_51537982 | 1.14 |
ENST00000525263.1
|
KLK12
|
kallikrein-related peptidase 12 |
chr3_-_48130707 | 1.11 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
chrX_-_23761317 | 1.09 |
ENST00000492081.1
ENST00000379303.5 ENST00000336430.7 |
ACOT9
|
acyl-CoA thioesterase 9 |
chr17_+_73717516 | 1.07 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
chr11_-_10590118 | 1.06 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr10_+_82168240 | 1.06 |
ENST00000372187.5
ENST00000372185.1 |
FAM213A
|
family with sequence similarity 213, member A |
chr19_-_57988871 | 1.05 |
ENST00000596831.1
ENST00000601768.1 ENST00000356584.3 ENST00000600175.1 ENST00000425074.3 ENST00000343280.4 ENST00000427512.2 |
AC004076.9
ZNF772
|
Uncharacterized protein zinc finger protein 772 |
chr7_+_142636603 | 1.05 |
ENST00000409607.3
|
C7orf34
|
chromosome 7 open reading frame 34 |
chr9_-_110251836 | 1.05 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr4_-_90756769 | 1.02 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chrX_+_153686614 | 1.02 |
ENST00000369682.3
|
PLXNA3
|
plexin A3 |
chr4_+_130692778 | 0.99 |
ENST00000513875.1
ENST00000508724.1 |
RP11-422J15.1
|
RP11-422J15.1 |
chr2_+_173940668 | 0.99 |
ENST00000375213.3
|
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
chr15_+_40675132 | 0.98 |
ENST00000608100.1
ENST00000557920.1 |
KNSTRN
|
kinetochore-localized astrin/SPAG5 binding protein |
chr9_+_116263639 | 0.97 |
ENST00000343817.5
|
RGS3
|
regulator of G-protein signaling 3 |
chr7_+_45067265 | 0.97 |
ENST00000474617.1
|
CCM2
|
cerebral cavernous malformation 2 |
chr19_-_51538118 | 0.96 |
ENST00000529888.1
|
KLK12
|
kallikrein-related peptidase 12 |
chr1_+_24645865 | 0.96 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr17_-_64216748 | 0.96 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr12_-_96390063 | 0.95 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
chr12_-_54653313 | 0.95 |
ENST00000550411.1
ENST00000439541.2 |
CBX5
|
chromobox homolog 5 |
chr1_+_24645807 | 0.95 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr9_+_116263778 | 0.94 |
ENST00000394646.3
|
RGS3
|
regulator of G-protein signaling 3 |
chr12_-_91572278 | 0.94 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr1_+_24646002 | 0.94 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr4_+_158141899 | 0.93 |
ENST00000264426.9
ENST00000506284.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr22_+_44576770 | 0.93 |
ENST00000444313.3
ENST00000416291.1 |
PARVG
|
parvin, gamma |
chr20_-_6103666 | 0.93 |
ENST00000536936.1
|
FERMT1
|
fermitin family member 1 |
chr11_-_19262486 | 0.92 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
chr2_+_85811525 | 0.92 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chrX_-_49041242 | 0.92 |
ENST00000453382.1
ENST00000540849.1 ENST00000536904.1 ENST00000432913.1 |
PRICKLE3
|
prickle homolog 3 (Drosophila) |
chrX_+_70798261 | 0.91 |
ENST00000373696.3
|
ACRC
|
acidic repeat containing |
chrX_-_54384425 | 0.90 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr4_+_158141843 | 0.88 |
ENST00000509417.1
ENST00000296526.7 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr12_+_123011776 | 0.88 |
ENST00000450485.2
ENST00000333479.7 |
KNTC1
|
kinetochore associated 1 |
chr11_+_76494253 | 0.87 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr1_-_120190396 | 0.87 |
ENST00000421812.2
|
ZNF697
|
zinc finger protein 697 |
chr1_-_85156090 | 0.86 |
ENST00000605755.1
ENST00000437941.2 |
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr5_+_169010638 | 0.86 |
ENST00000265295.4
ENST00000506574.1 ENST00000515224.1 ENST00000508247.1 ENST00000513941.1 |
SPDL1
|
spindle apparatus coiled-coil protein 1 |
chr3_-_48130314 | 0.86 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
chr19_-_51538148 | 0.86 |
ENST00000319590.4
ENST00000250351.4 |
KLK12
|
kallikrein-related peptidase 12 |
chr2_-_232791038 | 0.85 |
ENST00000295440.2
ENST00000409852.1 |
NPPC
|
natriuretic peptide C |
chr22_+_19938419 | 0.85 |
ENST00000412786.1
|
COMT
|
catechol-O-methyltransferase |
chr1_-_85156216 | 0.84 |
ENST00000342203.3
ENST00000370612.4 |
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
chr7_+_112063192 | 0.83 |
ENST00000005558.4
|
IFRD1
|
interferon-related developmental regulator 1 |
chr8_+_38261880 | 0.83 |
ENST00000527175.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr3_+_101504200 | 0.82 |
ENST00000422132.1
|
NXPE3
|
neurexophilin and PC-esterase domain family, member 3 |
chr6_-_43496605 | 0.82 |
ENST00000455285.2
|
XPO5
|
exportin 5 |
chr8_-_145016692 | 0.81 |
ENST00000357649.2
|
PLEC
|
plectin |
chr14_+_29241910 | 0.81 |
ENST00000399387.4
ENST00000552957.1 ENST00000548213.1 |
C14orf23
|
chromosome 14 open reading frame 23 |
chr22_+_19939026 | 0.81 |
ENST00000406520.3
|
COMT
|
catechol-O-methyltransferase |
chr19_-_42498369 | 0.81 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr2_-_228028829 | 0.80 |
ENST00000396625.3
ENST00000329662.7 |
COL4A4
|
collagen, type IV, alpha 4 |
chr16_-_3661578 | 0.80 |
ENST00000294008.3
|
SLX4
|
SLX4 structure-specific endonuclease subunit |
chr1_+_50574585 | 0.78 |
ENST00000371824.1
ENST00000371823.4 |
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
chr3_-_197476560 | 0.77 |
ENST00000273582.5
|
KIAA0226
|
KIAA0226 |
chr19_-_14629224 | 0.76 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr17_+_75450075 | 0.75 |
ENST00000592951.1
|
SEPT9
|
septin 9 |
chr5_-_1524015 | 0.74 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
chr8_-_16859690 | 0.73 |
ENST00000180166.5
|
FGF20
|
fibroblast growth factor 20 |
chr19_-_42498231 | 0.72 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr4_-_90757364 | 0.71 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr4_+_158141806 | 0.71 |
ENST00000393815.2
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr22_-_30234218 | 0.70 |
ENST00000307790.3
ENST00000542393.1 ENST00000397771.2 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
chr7_+_128577972 | 0.70 |
ENST00000357234.5
ENST00000477535.1 ENST00000479582.1 ENST00000464557.1 ENST00000402030.2 |
IRF5
|
interferon regulatory factor 5 |
chr8_+_80523321 | 0.70 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
chr1_+_115572415 | 0.70 |
ENST00000256592.1
|
TSHB
|
thyroid stimulating hormone, beta |
chr5_-_149535421 | 0.69 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
chr3_+_50712672 | 0.67 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
chr6_-_47009996 | 0.67 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
chrX_-_106243451 | 0.67 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
chrX_-_80065146 | 0.66 |
ENST00000373275.4
|
BRWD3
|
bromodomain and WD repeat domain containing 3 |
chr20_+_44036620 | 0.66 |
ENST00000372710.3
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr1_-_115238207 | 0.65 |
ENST00000520113.2
ENST00000369538.3 ENST00000353928.6 |
AMPD1
|
adenosine monophosphate deaminase 1 |
chr9_-_116037840 | 0.65 |
ENST00000374206.3
|
CDC26
|
cell division cycle 26 |
chr12_+_14518598 | 0.64 |
ENST00000261168.4
ENST00000538511.1 ENST00000545723.1 ENST00000543189.1 ENST00000536444.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
chr17_-_74707037 | 0.63 |
ENST00000355797.3
ENST00000375036.2 ENST00000449428.2 |
MXRA7
|
matrix-remodelling associated 7 |
chr1_-_154155675 | 0.63 |
ENST00000330188.9
ENST00000341485.5 |
TPM3
|
tropomyosin 3 |
chr1_-_175161890 | 0.63 |
ENST00000545251.2
ENST00000423313.1 |
KIAA0040
|
KIAA0040 |
chr4_+_158142750 | 0.62 |
ENST00000505888.1
ENST00000449365.1 |
GRIA2
|
glutamate receptor, ionotropic, AMPA 2 |
chr17_-_46716647 | 0.62 |
ENST00000608940.1
|
RP11-357H14.17
|
RP11-357H14.17 |
chr7_+_30634297 | 0.61 |
ENST00000389266.3
|
GARS
|
glycyl-tRNA synthetase |
chr5_-_158526693 | 0.61 |
ENST00000380654.4
|
EBF1
|
early B-cell factor 1 |
chr11_-_62314268 | 0.60 |
ENST00000257247.7
ENST00000531324.1 ENST00000378024.4 |
AHNAK
|
AHNAK nucleoprotein |
chr3_-_51994694 | 0.59 |
ENST00000395014.2
|
PCBP4
|
poly(rC) binding protein 4 |
chr9_+_88556036 | 0.59 |
ENST00000361671.5
ENST00000416045.1 |
NAA35
|
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
chr15_+_40531621 | 0.59 |
ENST00000560346.1
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6 |
chr17_+_1944790 | 0.59 |
ENST00000575162.1
|
DPH1
|
diphthamide biosynthesis 1 |
chr10_+_8096769 | 0.58 |
ENST00000346208.3
|
GATA3
|
GATA binding protein 3 |
chrX_-_154842538 | 0.57 |
ENST00000369439.4
|
TMLHE
|
trimethyllysine hydroxylase, epsilon |
chr1_+_205473720 | 0.57 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr13_-_33760216 | 0.56 |
ENST00000255486.4
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr11_+_1861399 | 0.55 |
ENST00000381905.3
|
TNNI2
|
troponin I type 2 (skeletal, fast) |
chr5_-_174871136 | 0.55 |
ENST00000393752.2
|
DRD1
|
dopamine receptor D1 |
chr17_-_10276319 | 0.54 |
ENST00000252172.4
ENST00000418404.3 |
MYH13
|
myosin, heavy chain 13, skeletal muscle |
chr11_-_36619771 | 0.54 |
ENST00000311485.3
ENST00000527033.1 ENST00000532616.1 |
RAG2
|
recombination activating gene 2 |
chr17_-_42767115 | 0.53 |
ENST00000315286.8
ENST00000588210.1 ENST00000457422.2 |
CCDC43
|
coiled-coil domain containing 43 |
chr20_+_44036900 | 0.53 |
ENST00000443296.1
|
DBNDD2
|
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr2_-_134326009 | 0.53 |
ENST00000409261.1
ENST00000409213.1 |
NCKAP5
|
NCK-associated protein 5 |
chr15_-_74501310 | 0.52 |
ENST00000423167.2
ENST00000432245.2 |
STRA6
|
stimulated by retinoic acid 6 |
chr7_+_142636440 | 0.51 |
ENST00000458732.1
|
C7orf34
|
chromosome 7 open reading frame 34 |
chr7_+_128379449 | 0.51 |
ENST00000479257.1
|
CALU
|
calumenin |
chr4_-_130692631 | 0.51 |
ENST00000500092.2
ENST00000509105.1 |
RP11-519M16.1
|
RP11-519M16.1 |
chr1_-_184943610 | 0.51 |
ENST00000367511.3
|
FAM129A
|
family with sequence similarity 129, member A |
chr1_-_203320617 | 0.50 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr5_-_158526756 | 0.50 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
chr10_+_8096631 | 0.50 |
ENST00000379328.3
|
GATA3
|
GATA binding protein 3 |
chr8_+_11561660 | 0.50 |
ENST00000526716.1
ENST00000335135.4 ENST00000528027.1 |
GATA4
|
GATA binding protein 4 |
chr5_+_74062806 | 0.49 |
ENST00000296802.5
|
NSA2
|
NSA2 ribosome biogenesis homolog (S. cerevisiae) |
chr18_-_45457192 | 0.49 |
ENST00000586514.1
ENST00000591214.1 ENST00000589877.1 |
SMAD2
|
SMAD family member 2 |
chr19_+_7562431 | 0.49 |
ENST00000361664.2
|
C19orf45
|
chromosome 19 open reading frame 45 |
chr2_-_25873079 | 0.49 |
ENST00000496972.2
|
DTNB
|
dystrobrevin, beta |
chr12_-_4754339 | 0.49 |
ENST00000228850.1
|
AKAP3
|
A kinase (PRKA) anchor protein 3 |
chr20_-_45981138 | 0.49 |
ENST00000446994.2
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr2_-_74692473 | 0.49 |
ENST00000535045.1
ENST00000409065.1 ENST00000414701.1 ENST00000448666.1 ENST00000233616.4 ENST00000452063.2 |
MOGS
|
mannosyl-oligosaccharide glucosidase |
chr11_-_11747257 | 0.49 |
ENST00000601641.1
|
AC131935.1
|
AC131935.1 |
chr13_-_96705624 | 0.48 |
ENST00000376747.3
ENST00000376712.4 ENST00000397618.3 ENST00000376714.3 |
UGGT2
|
UDP-glucose glycoprotein glucosyltransferase 2 |
chr21_-_46131470 | 0.48 |
ENST00000323084.4
|
TSPEAR
|
thrombospondin-type laminin G domain and EAR repeats |
chr12_-_96390108 | 0.46 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
chr17_-_73149921 | 0.45 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
chrX_+_49593888 | 0.45 |
ENST00000218068.6
|
PAGE4
|
P antigen family, member 4 (prostate associated) |
chr19_+_50879705 | 0.44 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
chrX_+_49593853 | 0.44 |
ENST00000376141.1
|
PAGE4
|
P antigen family, member 4 (prostate associated) |
chr3_+_183993797 | 0.44 |
ENST00000359140.4
ENST00000404464.3 ENST00000357474.5 |
ECE2
|
endothelin converting enzyme 2 |
chr2_+_85839218 | 0.44 |
ENST00000448971.1
ENST00000442708.1 ENST00000450066.2 |
USP39
|
ubiquitin specific peptidase 39 |
chr1_-_204165610 | 0.43 |
ENST00000367194.4
|
KISS1
|
KiSS-1 metastasis-suppressor |
chr5_+_169064245 | 0.43 |
ENST00000256935.8
|
DOCK2
|
dedicator of cytokinesis 2 |
chr4_+_71248795 | 0.43 |
ENST00000304915.3
|
SMR3B
|
submaxillary gland androgen regulated protein 3B |
chr8_+_9009296 | 0.43 |
ENST00000521718.1
|
RP11-10A14.4
|
Uncharacterized protein |
chr1_+_54411715 | 0.42 |
ENST00000371370.3
ENST00000371368.1 |
LRRC42
|
leucine rich repeat containing 42 |
chr12_+_49212514 | 0.41 |
ENST00000301050.2
ENST00000548279.1 ENST00000547230.1 |
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr1_+_165600083 | 0.41 |
ENST00000367889.3
|
MGST3
|
microsomal glutathione S-transferase 3 |
chr5_-_176943917 | 0.41 |
ENST00000330503.7
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
chr12_+_115800817 | 0.40 |
ENST00000547948.1
|
RP11-116D17.1
|
HCG2038717; Uncharacterized protein |
chr17_+_19281034 | 0.39 |
ENST00000308406.5
ENST00000299612.7 |
MAPK7
|
mitogen-activated protein kinase 7 |
chr12_+_54393880 | 0.39 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chr20_+_20348740 | 0.39 |
ENST00000310227.1
|
INSM1
|
insulinoma-associated 1 |
chr5_+_161274940 | 0.38 |
ENST00000393943.4
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
chr6_-_150039170 | 0.38 |
ENST00000458696.2
ENST00000392273.3 |
LATS1
|
large tumor suppressor kinase 1 |
chr11_-_18765389 | 0.38 |
ENST00000477854.1
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
chr12_+_29376592 | 0.38 |
ENST00000182377.4
|
FAR2
|
fatty acyl CoA reductase 2 |
chr8_-_87242589 | 0.38 |
ENST00000419776.2
ENST00000297524.3 |
SLC7A13
|
solute carrier family 7 (anionic amino acid transporter), member 13 |
chr22_+_23522552 | 0.38 |
ENST00000359540.3
ENST00000398512.5 |
BCR
|
breakpoint cluster region |
chr12_+_29376673 | 0.38 |
ENST00000547116.1
|
FAR2
|
fatty acyl CoA reductase 2 |
chr19_-_15236173 | 0.37 |
ENST00000527093.1
|
ILVBL
|
ilvB (bacterial acetolactate synthase)-like |
chr7_-_558876 | 0.37 |
ENST00000354513.5
ENST00000402802.3 |
PDGFA
|
platelet-derived growth factor alpha polypeptide |
chr2_-_47168850 | 0.37 |
ENST00000409207.1
|
MCFD2
|
multiple coagulation factor deficiency 2 |
chr1_-_160616804 | 0.36 |
ENST00000538290.1
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1 |
chr2_-_24583583 | 0.36 |
ENST00000355123.4
|
ITSN2
|
intersectin 2 |
chr12_-_52911718 | 0.35 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr18_-_5419797 | 0.35 |
ENST00000542146.1
ENST00000427684.2 |
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
chr2_+_198669365 | 0.35 |
ENST00000428675.1
|
PLCL1
|
phospholipase C-like 1 |
chr1_-_161208013 | 0.34 |
ENST00000515452.1
ENST00000367983.4 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.9 | 3.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.9 | 2.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.8 | 2.5 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.7 | 2.2 | GO:2000283 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.7 | 4.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.7 | 7.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.7 | 3.6 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.5 | 3.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 1.9 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.4 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 1.0 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.3 | 1.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 9.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.7 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.3 | 2.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 0.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.3 | 3.5 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 1.4 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.3 | 0.8 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.3 | 0.8 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.3 | 1.1 | GO:1901535 | pro-T cell differentiation(GO:0002572) cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.3 | 0.8 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.3 | 0.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.3 | 3.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.7 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.2 | 0.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 1.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.9 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.2 | 1.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0003285 | septum secundum development(GO:0003285) |
0.2 | 2.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.5 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.2 | 1.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.6 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 3.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 2.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 0.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.7 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.5 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.1 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 1.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.3 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 1.0 | GO:0051918 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) negative regulation of smooth muscle cell apoptotic process(GO:0034392) negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 1.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.4 | GO:1900238 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.7 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 4.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 1.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.2 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 3.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 1.4 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.2 | GO:0044828 | negative regulation of CREB transcription factor activity(GO:0032792) negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 1.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.0 | 3.5 | GO:0070268 | cornification(GO:0070268) |
0.0 | 1.9 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 1.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.2 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 1.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 7.3 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.1 | GO:1903301 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 1.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 1.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.6 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.5 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 1.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.3 | 2.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 4.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 6.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.8 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.3 | 3.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 4.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 2.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 1.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 1.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) Flemming body(GO:0090543) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 7.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 2.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 3.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.8 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 1.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 2.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 3.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 2.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 1.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 1.6 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0099568 | cell cortex(GO:0005938) cytoplasmic region(GO:0099568) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 2.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 2.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.9 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.3 | 4.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 1.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.3 | 0.8 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.3 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 5.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 7.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.9 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 3.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 1.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 1.7 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.5 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.2 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 3.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.6 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 3.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.3 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.1 | 3.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 5.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 2.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 4.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 3.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.5 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 8.2 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 3.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 10.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 8.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 7.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 4.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 3.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 3.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 7.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 4.7 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 2.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 10.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 3.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 4.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 1.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 1.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 2.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 1.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |